Regeneus is a Sydney based regenerative medicine company founded in September 2007 that is focused on using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for humans and animals. Regenerative medicine is a rapidly growing multidisciplinary speciality that is focused on the repair or regeneration of cells, tissues and organs. The primary goal is to enhance the body's natural ability to replace tissue damaged or destroyed by injury or disease.
Regeneus has a focus on adipose tissue as it is a rich source of regenerative cells (including mesenchymal stem cells) that possess anti-inflammatory and repair and regenerative qualities. The high numbers of regenerative cells within adipose tissue - there are approximately 500 fold more MSCs from equivalent amounts of fat versus bone marrow - overcome the need to culture cells. Regeneus' proprietary cell mixture contains stem cells and adipocytes, that have been shown in a third-party pre-clinical study to perform better therapeutically than a cell mixture that did not contain adipocytes.
Regeneus was founded in September 2007 by experienced biotechnology innovators to take advantage of the rapid advances in cell-based regenerative medicine, and the opportunity to develop and commercialise innovative adipose-derived cell therapies to treat a range of orthopaedic and other inflammatory diseases in people and animals.
Regeneus is committed to developing its proprietary regenerative cell therapy in order to provide physicians and veterinarians with next generation tools for the treatment of and functional restoration of damaged or diseased tissues. The multi potential use of our regenerative cell products provides the basis for a cell therapy platform that is able to address a wide range of inflammatory conditions.
To improve the lives of people and animals through innovative cellular therapies.
A future where regenerative medicine plays an integral role in human and animal healthcare.
At Regeneus, we value:
- Attracting and developing the best talent;
- Science-based innovation and collaboration;
- Solving significant problems;
- Product and results driven;
- Quality in everything we do.